Inhibition of fibroblast activation protein ameliorates cartilage matrix degradation and osteoarthritis progression. 2023

Aoyuan Fan, and Genbin Wu, and Jianfang Wang, and Laiya Lu, and Jingyi Wang, and Hanjing Wei, and Yuxi Sun, and Yanhua Xu, and Chunyang Mo, and Xiaoying Zhang, and Zhiying Pang, and Zhangyi Pan, and Yiming Wang, and Liangyu Lu, and Guojian Fu, and Mengqiu Ma, and Qiaoling Zhu, and Dandan Cao, and Jiachen Qin, and Feng Yin, and Rui Yue
Department of Joint Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200092, China.

Fibroblast activation protein (Fap) is a serine protease that degrades denatured type I collagen, α2-antiplasmin and FGF21. Fap is highly expressed in bone marrow stromal cells and functions as an osteogenic suppressor and can be inhibited by the bone growth factor Osteolectin (Oln). Fap is also expressed in synovial fibroblasts and positively correlated with the severity of rheumatoid arthritis (RA). However, whether Fap plays a critical role in osteoarthritis (OA) remains poorly understood. Here, we found that Fap is significantly elevated in osteoarthritic synovium, while the genetic deletion or pharmacological inhibition of Fap significantly ameliorated posttraumatic OA in mice. Mechanistically, we found that Fap degrades denatured type II collagen (Col II) and Mmp13-cleaved native Col II. Intra-articular injection of rFap significantly accelerated Col II degradation and OA progression. In contrast, Oln is expressed in the superficial layer of articular cartilage and is significantly downregulated in OA. Genetic deletion of Oln significantly exacerbated OA progression, which was partially rescued by Fap deletion or inhibition. Intra-articular injection of rOln significantly ameliorated OA progression. Taken together, these findings identify Fap as a critical pathogenic factor in OA that could be targeted by both synthetic and endogenous inhibitors to ameliorate articular cartilage degradation.

UI MeSH Term Description Entries

Related Publications

Aoyuan Fan, and Genbin Wu, and Jianfang Wang, and Laiya Lu, and Jingyi Wang, and Hanjing Wei, and Yuxi Sun, and Yanhua Xu, and Chunyang Mo, and Xiaoying Zhang, and Zhiying Pang, and Zhangyi Pan, and Yiming Wang, and Liangyu Lu, and Guojian Fu, and Mengqiu Ma, and Qiaoling Zhu, and Dandan Cao, and Jiachen Qin, and Feng Yin, and Rui Yue
January 2019, Journal of molecular medicine (Berlin, Germany),
Aoyuan Fan, and Genbin Wu, and Jianfang Wang, and Laiya Lu, and Jingyi Wang, and Hanjing Wei, and Yuxi Sun, and Yanhua Xu, and Chunyang Mo, and Xiaoying Zhang, and Zhiying Pang, and Zhangyi Pan, and Yiming Wang, and Liangyu Lu, and Guojian Fu, and Mengqiu Ma, and Qiaoling Zhu, and Dandan Cao, and Jiachen Qin, and Feng Yin, and Rui Yue
December 2022, European journal of pharmacology,
Aoyuan Fan, and Genbin Wu, and Jianfang Wang, and Laiya Lu, and Jingyi Wang, and Hanjing Wei, and Yuxi Sun, and Yanhua Xu, and Chunyang Mo, and Xiaoying Zhang, and Zhiying Pang, and Zhangyi Pan, and Yiming Wang, and Liangyu Lu, and Guojian Fu, and Mengqiu Ma, and Qiaoling Zhu, and Dandan Cao, and Jiachen Qin, and Feng Yin, and Rui Yue
September 1994, Annals of the New York Academy of Sciences,
Aoyuan Fan, and Genbin Wu, and Jianfang Wang, and Laiya Lu, and Jingyi Wang, and Hanjing Wei, and Yuxi Sun, and Yanhua Xu, and Chunyang Mo, and Xiaoying Zhang, and Zhiying Pang, and Zhangyi Pan, and Yiming Wang, and Liangyu Lu, and Guojian Fu, and Mengqiu Ma, and Qiaoling Zhu, and Dandan Cao, and Jiachen Qin, and Feng Yin, and Rui Yue
June 2017, Arthritis & rheumatology (Hoboken, N.J.),
Aoyuan Fan, and Genbin Wu, and Jianfang Wang, and Laiya Lu, and Jingyi Wang, and Hanjing Wei, and Yuxi Sun, and Yanhua Xu, and Chunyang Mo, and Xiaoying Zhang, and Zhiying Pang, and Zhangyi Pan, and Yiming Wang, and Liangyu Lu, and Guojian Fu, and Mengqiu Ma, and Qiaoling Zhu, and Dandan Cao, and Jiachen Qin, and Feng Yin, and Rui Yue
January 2024, International immunopharmacology,
Aoyuan Fan, and Genbin Wu, and Jianfang Wang, and Laiya Lu, and Jingyi Wang, and Hanjing Wei, and Yuxi Sun, and Yanhua Xu, and Chunyang Mo, and Xiaoying Zhang, and Zhiying Pang, and Zhangyi Pan, and Yiming Wang, and Liangyu Lu, and Guojian Fu, and Mengqiu Ma, and Qiaoling Zhu, and Dandan Cao, and Jiachen Qin, and Feng Yin, and Rui Yue
December 2022, Life (Basel, Switzerland),
Aoyuan Fan, and Genbin Wu, and Jianfang Wang, and Laiya Lu, and Jingyi Wang, and Hanjing Wei, and Yuxi Sun, and Yanhua Xu, and Chunyang Mo, and Xiaoying Zhang, and Zhiying Pang, and Zhangyi Pan, and Yiming Wang, and Liangyu Lu, and Guojian Fu, and Mengqiu Ma, and Qiaoling Zhu, and Dandan Cao, and Jiachen Qin, and Feng Yin, and Rui Yue
November 2018, Immunology letters,
Aoyuan Fan, and Genbin Wu, and Jianfang Wang, and Laiya Lu, and Jingyi Wang, and Hanjing Wei, and Yuxi Sun, and Yanhua Xu, and Chunyang Mo, and Xiaoying Zhang, and Zhiying Pang, and Zhangyi Pan, and Yiming Wang, and Liangyu Lu, and Guojian Fu, and Mengqiu Ma, and Qiaoling Zhu, and Dandan Cao, and Jiachen Qin, and Feng Yin, and Rui Yue
January 2015, Arthritis research & therapy,
Aoyuan Fan, and Genbin Wu, and Jianfang Wang, and Laiya Lu, and Jingyi Wang, and Hanjing Wei, and Yuxi Sun, and Yanhua Xu, and Chunyang Mo, and Xiaoying Zhang, and Zhiying Pang, and Zhangyi Pan, and Yiming Wang, and Liangyu Lu, and Guojian Fu, and Mengqiu Ma, and Qiaoling Zhu, and Dandan Cao, and Jiachen Qin, and Feng Yin, and Rui Yue
January 2012, Biochimica et biophysica acta,
Aoyuan Fan, and Genbin Wu, and Jianfang Wang, and Laiya Lu, and Jingyi Wang, and Hanjing Wei, and Yuxi Sun, and Yanhua Xu, and Chunyang Mo, and Xiaoying Zhang, and Zhiying Pang, and Zhangyi Pan, and Yiming Wang, and Liangyu Lu, and Guojian Fu, and Mengqiu Ma, and Qiaoling Zhu, and Dandan Cao, and Jiachen Qin, and Feng Yin, and Rui Yue
November 2016, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,
Copied contents to your clipboard!